🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the producers of Tylenol, claiming the corporations concealed potential risks that the medication presented to children's brain development.

The lawsuit follows four weeks after Donald Trump advocated an unsubstantiated connection between consuming Tylenol - also known as acetaminophen - during pregnancy and autism in children.

Paxton is filing suit against J&J, which previously sold the medication, the sole analgesic approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a statement, he said they "betrayed America by gaining financially from discomfort and marketing drugs ignoring the dangers."

Kenvue asserts there is insufficient reliable data connecting acetaminophen to autism.

"These corporations deceived for years, intentionally threatening countless individuals to boost earnings," Paxton, a Republican, declared.

The manufacturer said in a statement that it was "very worried by the spread of false claims on the reliability of paracetamol and the likely effects that could have on the welfare of women and children in America."

On its website, the company also stated it had "consistently assessed the pertinent research and there is insufficient valid information that indicates a verified association between consuming acetaminophen and autism."

Organizations speaking for medical professionals and medical practitioners agree.

ACOG has declared paracetamol - the main ingredient in Tylenol - is one of the few options for pregnant women to treat discomfort and fever, which can create serious health risks if not addressed.

"In multiple decades of studies on the consumption of paracetamol in gestation, no reliable research has definitively established that the use of paracetamol in any trimester of gestation results in brain development issues in children," the organization said.

This legal action references recent announcements from the former administration in asserting the medication is reportedly hazardous.

In recent weeks, the former president raised alarms from health experts when he told expectant mothers to "fight like hell" not to use acetaminophen when sick.

The FDA then released a statement that physicians should consider limiting the consumption of acetaminophen, while also declaring that "a direct connection" between the medication and autism spectrum disorder in minors has not been proven.

The Health Department head RFK Jr, who supervises the Food and Drug Administration, had pledged in spring to conduct "comprehensive study program" that would determine the origin of autism in a short period.

But experts advised that discovering a unique factor of autism - believed by scientists to be the consequence of a complicated interplay of genetic and environmental factors - would not be simple.

Autism is a type of enduring cognitive variation and impairment that affects how individuals experience and engage with the world, and is identified using physician assessments.

In his legal document, Paxton - aligned with the former president who is running for US Senate - asserts the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism.

The lawsuit seeks to make the companies "remove any promotional materials" that claims acetaminophen is reliable for women during pregnancy.

This legal action mirrors the grievances of a assembly of mothers and fathers of young ones with autism spectrum disorder and ADHD who filed suit against the makers of Tylenol in recently.

Judicial authorities rejected the legal action, saying investigations from the parents' expert witnesses was not conclusive.